Showing 1,101 - 1,120 results of 198,101 for search '(( i a decrease ) OR ( 5 ((((wt decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 2.51s Refine Results
  1. 1101
  2. 1102
  3. 1103
  4. 1104
  5. 1105
  6. 1106
  7. 1107

    Image_5_TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1.tif by Takahiko Akagi (13138338)

    Published 2022
    “…In this study, we generated TRAPS mutant mice and analyzed their phenotypes. Three Tnfrsf1a mutant strains were generated by introducing T79M, G87V, or T90I mutation. …”
  8. 1108
  9. 1109

    MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1 by FeiYan Xie (4503430)

    Published 2017
    “…Ectopic miR-193a overexpression inhibited the proliferation, colony formation, migration, and invasion of MDA-MB-231 and BT549 cells. miR-193a reduced Wilms’ tumor 1 (<i>WT1</i>) expression and repressed luciferase reporter activity by binding <i>WT1</i> coding region sequences; mutation of the predicted miR-193a binding site abolished this effect. miR-193a and <i>WT1</i> expression were significantly inversely correlated in breast cancer tissues. …”
  10. 1110
  11. 1111

    Fig 5 - by Moez Amri (10872935)

    Published 2021
    Subjects:
  12. 1112
  13. 1113
  14. 1114

    NBCe1 protein expression regulation by D<sub>1</sub>-like (D<sub>1</sub>R and D<sub>5</sub>R) dopamine receptor agonist in hRPTCs carrying wild-type (WT) <i>SLC4A5</i>. by John J. Gildea (845025)

    Published 2018
    “…<p>NBCe1 protein expression is decreased following an increase in intracellular sodium (↑Na<sup>+</sup>) (10 μmol monensin/L, 24 h) (N = 4, *P<0.001 vs VEH, one-way ANOVA, Tukey’s test) in WT <i>SLC4A5</i> hRPTC. …”
  15. 1115

    <i>cd9b</i> MO caused a decrease in neuromasts deposited at 52 hpf. by Katherine S. Marsay (11772718)

    Published 2021
    “…B-G: Representative images of WISH of <i>claudin b</i> at 52 hpf of (b) uninjected embryos, (c) embryos with 0.5 μM Mismatch, (d) 0.1 μM <i>cd9b</i> MO1, (e) 0.1 μM <i>cd9b</i> i2e3 MO1, (f) 0.2 μM <i>cd9b</i> MO1, (g) 0.2 μM <i>cd9b</i> i2e3 MO. …”
  16. 1116
  17. 1117
  18. 1118
  19. 1119
  20. 1120

    Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…Results are the mean ± SD of two independent experiments containing 8 replicates for each condition. * = <i>p</i><0.05, ** = <i>p</i><0.01, *** = <i>p</i><0.001, significant decrease compared to untreated cells (TA) or to siRNA Control (Kruskal & Wallis followed by Tukey and Dunnet test).…”